Premium
Treatment protocols for demodicosis: an evidence‐based review
Author(s) -
Mueller Ralf S.
Publication year - 2004
Publication title -
veterinary dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.744
H-Index - 60
eISSN - 1365-3164
pISSN - 0959-4493
DOI - 10.1111/j.1365-3164.2004.00344.x
Subject(s) - moxidectin , amitraz , demodicosis , ivermectin , medicine , adverse effect , dermatology , avermectin , acaricide , pharmacology , veterinary medicine , biology , toxicology , anatomy
Publications discussing the treatment of demodicosis in the dog and cat are reviewed. Based on the evidence in the literature, amitraz rinses at 0.025–0.06% every 7–14 days, and oral daily ivermectin at 300 µg kg −1 , milbemycin at 2 mg kg −1 and moxidectin at 400 µg kg −1 , respectively, can all be recommended for the treatment of generalized canine demodicosis. Ivermectin and moxidectin should be initiated at lower doses and patients monitored for possible adverse effects during therapy. In cats, 2% lime sulfur dips and amitraz rinses at 0.0125–0.025% have been used successfully.